Position Paper on Emerging Ibogaine Regulation, Ethical Governance, and Gabon–United States Cooperation
In Response to Colorado HB26-1325 and Expanding International Interest in Ibogaine
Executive Summary
The rapid emergence of Ibogaine policy initiatives in the United States — particularly Colorado’s proposed House Bill 26-1325 — marks a significant turning point in the global conversation surrounding psychedelic medicine, addiction treatment, and natural medicine regulation.
Colorado’s legislative framework signals that Ibogaine is moving beyond isolated research and into institutional policy development, public health strategy, and regulated therapeutic infrastructure. Importantly, the legislation also reflects a growing recognition within U.S. policy discussions that ethical governance must include benefit-sharing considerations and acknowledgment of Indigenous and traditional relationships connected to Iboga.
As international interest accelerates, ROOTS Fellowship Foundation believes there is an urgent need for coordinated international dialogue. Such dialogue must recognize Gabon as the primary sovereign steward of Iboga, protect traditional knowledge systems and spiritual lineages, and encourage ethical scientific collaboration. It must also work to prevent exploitative commercialization and ecological depletion. Finally, it must establish reciprocal frameworks between source countries and emerging regulatory jurisdictions.
ROOTS Fellowship Foundation supports responsible scientific and medical research into Ibogaine while emphasizing that future governance frameworks must remain grounded in sovereignty, reciprocity, ecological stewardship, and cultural respect.
1. Introduction
Iboga is a sacred plant medicine historically connected to spiritual, ceremonial, and healing traditions in Central Africa, particularly within Gabonese cultural and spiritual life.
Over the past decade, growing scientific and clinical attention has focused on Ibogaine — a psychoactive alkaloid derived from Iboga — due to emerging research in areas including addiction treatment, opioid dependency, PTSD and trauma, depression and mental health disorders, and neuroplasticity and neurological recovery.
This rising international interest has generated increasing momentum among medical researchers, veterans’ advocacy organizations, psychedelic policy reform advocates, public health officials, and state governments across the United States. Colorado has now become one of the most influential jurisdictions in shaping this next phase of psychedelic policy development.
2. Colorado HB26-1325: Why It Matters
Colorado House Bill 26-1325 proposes the creation of a formal Ibogaine Research Pilot Program operating under the state’s Behavioral Health Administration as part of Colorado’s broader Natural Medicine Program framework. The bill represents a substantial evolution beyond limited academic research. The legislation creates the foundation for long-term regulatory infrastructure surrounding Ibogaine in Colorado.
Key components of HB26-1325 include authorization for up to five pilot treatment and research sites, state-supported grant mechanisms, and coordination between Colorado agencies and federal regulators. The bill also provides expanded rulemaking authority regarding Ibogaine administration and manufacturing, integration into Colorado’s Natural Medicine oversight framework, and the development of data collection and safety standards.
Most notably, the legislation includes provisions requiring entities involved in Ibogaine-related cultivation, manufacturing, dispensing, or administration to establish benefit-sharing plans developed in consultation with Indigenous communities connected to Iboga and Ibogaine traditions. This marks an important shift within U.S. psychedelic policy discussions. It suggests growing recognition that psychedelic medicines cannot be ethically separated from the communities, ecosystems, and traditional knowledge systems connected to their origins.
Colorado’s framework may ultimately influence other U.S. state policies, federal psychedelic research discussions, international investment and commercialization, and emerging global governance standards surrounding Ibogaine. For this reason, ROOTS Fellowship Foundation believes the implications of HB26-1325 extend well beyond Colorado itself.
3. ROOTS Fellowship Foundation Position
3.1 Recognition of Scientific and Therapeutic Potential
ROOTS Fellowship Foundation recognizes the growing body of scientific and clinical research surrounding Ibogaine and acknowledges the urgent need for innovative responses to addiction, trauma, and mental health crises. We support responsible scientific research, ethical medical oversight, evidence-based public policy, international collaboration rooted in transparency and reciprocity, and appropriate safety and regulatory standards.
We also recognize the importance of exploring new treatment paradigms for veterans, individuals struggling with addiction, and communities impacted by severe mental health challenges.
3.2 Gabonese Sovereignty Must Remain Central
ROOTS Fellowship Foundation affirms that Iboga is not merely a pharmaceutical resource or emerging commercial market. Iboga is a sacred cultural, ecological, and spiritual heritage resource deeply connected to Gabonese identity, traditional practices, and knowledge systems.
As international regulation expands, ROOTS believes Gabon’s sovereign role must remain central to any future governance framework involving Iboga or Ibogaine. This includes recognition of Gabon as the country of origin and primary steward of Iboga, inclusion of traditional knowledge holders in international dialogue, protection against exploitative extraction and commercialization, development of ethical benefit-sharing frameworks, and respect for cultural and spiritual traditions connected to Iboga.
Colorado’s inclusion of Indigenous consultation and benefit-sharing language represents an important acknowledgment of these concerns. However, ROOTS believes future policy frameworks should evolve toward direct international engagement with Gabonese institutions, communities, and cultural stakeholders.
4. Ethical Concerns in the Global Expansion of Ibogaine
The accelerating medicalization and commercialization of psychedelic therapies creates important ethical challenges that require proactive international coordination. ROOTS Fellowship Foundation believes the rapid expansion of Ibogaine interest presents significant risks, including ecological pressure on Iboga populations, unsustainable sourcing practices, cultural appropriation and erasure, and commercial extraction disconnected from source communities. Also of concern are reductionist biomedical narratives that ignore spiritual and cultural dimensions, and fragmented regulatory systems that lack international coordination.
As psychedelic medicine becomes increasingly institutionalized, there is a danger that market forces may outpace ethical governance structures. ROOTS encourages policymakers, researchers, and industry stakeholders to approach Ibogaine within a broader framework that encompasses ecology, Indigenous rights, cultural heritage, reciprocity, long-term sustainability, and international diplomacy.
5. Why Colorado Matters Internationally
Colorado’s legislative developments represent more than a state-level policy experiment. HB26-1325 demonstrates that Ibogaine is entering mainstream policy, healthcare, and regulatory discussions in the United States. The legislation establishes public-sector research infrastructure, regulatory oversight mechanisms, government-backed pilot programs, and potential pathways toward future therapeutic access.
The bill also reflects growing institutional awareness that ethical governance requires acknowledgment of Indigenous and traditional relationships connected to plant medicines. ROOTS Fellowship Foundation believes this moment presents a strategic opportunity for international dialogue, bilateral cooperation, ethical governance development, cross-cultural partnership, and ecological stewardship initiatives.
Without such frameworks, there is a significant risk that commercialization and medicalization could proceed without sufficient accountability to source communities and traditional custodians.
6. The Need for Gabon–United States Dialogue
ROOTS Fellowship Foundation supports the development of structured dialogue between Gabonese and American stakeholders on matters including ethical research collaboration, conservation and sustainability, traditional knowledge protections, regulatory coordination, benefit-sharing principles, and international governance standards.
ROOTS does not seek to replace governmental or diplomatic institutions. Rather, ROOTS seeks to support informed, ethical, and culturally grounded dialogue among governments, researchers, civil society organizations, traditional knowledge communities, public health experts, and ethical policy leaders. The growing internationalization of Ibogaine policy makes proactive cooperation increasingly important.
7. Recommendations
ROOTS Fellowship Foundation recommends that the following principles guide future Ibogaine policy development across governance, research, ecology, community inclusion, and international cooperation.
GOVERNANCE
Future frameworks should recognize Gabonese sovereignty and stewardship as foundational, establish international consultation frameworks, and apply rigorous ethical oversight standards throughout all stages of policy and program development.
RESEARCH
Research efforts should be multidisciplinary and include anthropological and cultural expertise alongside scientific inquiry. Full transparency regarding sourcing and funding is essential to maintaining public trust and ethical integrity.
ECOLOGY
Sustainable sourcing standards and robust conservation protections must be established to ensure the long-term health of Iboga populations. Active prevention of ecological depletion should be treated as a non-negotiable governance priority.
COMMUNITY INCLUSION
The meaningful participation of traditional knowledge holders must be central to governance processes. This includes fair compensation and benefit-sharing arrangements, and respectful representation of the spiritual traditions connected to Iboga.
INTERNATIONAL COOPERATION
Bilateral dialogue mechanisms should be established between Gabon and interested jurisdictions, supported by educational and scientific exchange programs. Shared ethical frameworks should guide governance across national boundaries and regulatory systems.
8. Conclusion
Colorado HB26-1325 reflects a major shift in the global trajectory of Ibogaine policy and psychedelic medicine regulation. Importantly, the legislation also signals growing awareness that ethical governance must include recognition of Indigenous and traditional relationships connected to plant medicines and natural healing systems.
ROOTS Fellowship Foundation believes this moment presents an opportunity to shape international cooperation proactively rather than reactively. Future Ibogaine governance should not be driven solely by markets, investment, or medical systems. It must also be grounded in sovereignty, reciprocity, ecological stewardship, cultural respect, ethical scientific collaboration, and the protection of traditional knowledge systems.
As international interest continues to grow, Gabon’s sovereign and cultural relationship to Iboga must remain central to the future of global dialogue surrounding Ibogaine.